{
  "id": "5e323780fbd6abf43b000055",
  "type": "yesno",
  "question": "Is there an increased risk of meningiomas in atomic bomb survivors?",
  "ideal_answer": "Yes, the incidence of meningiomas is increased in atomic bomb survivors.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/12381708",
    "http://www.ncbi.nlm.nih.gov/pubmed/8707402",
    "http://www.ncbi.nlm.nih.gov/pubmed/15378499",
    "http://www.ncbi.nlm.nih.gov/pubmed/10408177"
  ],
  "snippets": [
    {
      "text": "RESULTS: Meningioma was the most common tumor among clinically diagnosed tumors, followed by neuroepithelial tumor, schwannoma, and pituitary tumor. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15378499",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The predominance of meningiomas over neuroepithelial tumors in the Japanese population was noteworthy and warrants further investigation. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15378499",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Risk increases, although not statistically significant, were seen for meningiomas (ERR(Sv) = 0.6, 95% CI = -0.01 to 1.8), gliomas (ERR(Sv) = 0.6, 95% CI = -0.2 to 2.0), other nervous system tumors (ERR(Sv) = 0.5, 95% CI = <-0.2 to 2.2), and pituitary tumors (ERR(Sv) = 1.0, 95% CI = <-0.2 to 3.5).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12381708",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "High incidence of meningioma among Hiroshima atomic bomb survivors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10408177",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The incidence of meningioma among Hiroshima atomic bomb survivors has increased since 1975. There was a significant correlation between the incidence and the dose of radiation to the brain. The present findings strongly suggest that meningioma is one of the tumors induced by atomic bombing in Hiroshima.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10408177",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Incidence of intracranial meningiomas in Nagasaki atomic-bomb survivors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8707402",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The analysis showed a high correlation between incidence of meningiomas and distance from the hypocenter. The incidence among Nagasaki atomic-bomb survivors over 40 years of age, especially in those proximally exposed, appears to be increasing, in inverse proportion to the exposure distance, since 1981, 36 years after the explosion of the atomic bomb.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8707402",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The incidence of meningioma among Hiroshima atomic bomb survivors has increased since 1975.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10408177",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The present findings strongly suggest that meningioma is one of the tumors induced by atomic bombing in Hiroshima.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10408177",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The incidences of meningioma among the survivors of Hiroshima in 5-year intervals since 1975 were 5.3, 7.4, 10.1, and 14.9, respectively.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/10408177",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The analysis showed a high correlation between incidence of meningiomas and distance from the hypocenter.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/8707402",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}